about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorep...
Read More
73.43
7.09
(10.69%)
1.8M
XNAS Volume
XNAS 17 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Cg Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..